Top Story

Yale School of Medicine appoints chair of surgery department

Yale School of Medicine appoints chair of surgery department
November 18, 2017

Nita Ahuja, MD, has been named chair of the department of surgery at Yale School of Medicine.

Ahuja also will serve as chief of surgery at Yale New Haven Hospital.

In the Journals Plus

Radiotherapy shows potential role in treatment of Hodgkin lymphoma subtype

November 17, 2017
Radiotherapy prolonged OS among patients with all stages of nodular lymphocytic Hodgkin lymphoma, including those with B-symptoms, according to study results. However…
Meeting News

High compliance with Optune linked to greatest survival benefit for glioblastoma

November 17, 2017
Patients with newly diagnosed glioblastoma who used the Optune device more than 90% of the time had the greatest chance for survival, according to a company-issued press…

ASCO expands enrollment for TAPUR study

November 17, 2017
ASCO announced four cohorts of Targeted Agent and Profiling Utilization Registry, or TAPUR, will enroll additional patients with a variety of cancers. The combination of…
Meeting NewsVideo

VIDEO: Physicians should take special considerations for metastatic renal cell carcinoma management

November 17, 2017
MIAMI Saby George, MD, FACS, offered background in special considerations that should be taken when treating patients with metastatic renal cell carcinoma at…
More Headlines »

Immune Checkpoint Inhibitors for Advanced Melanoma: Clinical Updates and Multidisciplinary Strategies

This activity is supported by an educational grant from Bristol-Myers Squibb.

Incidence rates of melanoma in the United States continue to rise, with an estimated 87,110 new cases being diagnosed…
More »

Baseball great Mike Schmidt became ‘concerned about dying’ after melanoma diagnosis

September 25, 2017
More »
Resource Centers


Expert Update: What's New in Essential Thrombocythemia

This activity is supported by an educational grant from Incyte Corporation.

Appropriate early diagnosis and initiation of therapy is essential in the management of myeloproliferative neoplasms…
More »
Current Issues
View the Current Issue
HemOnc Today